BRPI0417801A - incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas - Google Patents

incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas

Info

Publication number
BRPI0417801A
BRPI0417801A BRPI0417801-7A BRPI0417801A BRPI0417801A BR PI0417801 A BRPI0417801 A BR PI0417801A BR PI0417801 A BRPI0417801 A BR PI0417801A BR PI0417801 A BRPI0417801 A BR PI0417801A
Authority
BR
Brazil
Prior art keywords
hydroxytryptophan
cell proteins
mammalian cell
selective incorporation
incorporating
Prior art date
Application number
BRPI0417801-7A
Other languages
English (en)
Inventor
Zhiwen Zhang
Lital Alfonta
Peter Schultz
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of BRPI0417801A publication Critical patent/BRPI0417801A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"INCORPORAçãO SELETIVA DE 5-HIDROXITRIPTOFANO EM PROTEìNAS DE CéLULAS MAMìFERAS". Esta invenção provê métodos e composições para incorporação de um aminoácido não natural em um peptídeo utilizando RNAt sistetase aminoacil ortogonal / per RNAt. Em particular, um par ortogonal é provido para incorporar 5-hidróxi-L-triptofano em uma posição por uma mutação opalaa.
BRPI0417801-7A 2003-12-18 2004-12-16 incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas BRPI0417801A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53131203P 2003-12-18 2003-12-18
US54876104P 2004-02-26 2004-02-26
PCT/US2004/042535 WO2006001832A2 (en) 2003-12-18 2004-12-16 Selective incorporation of 5-hyroxytryptophan into proteins in mammalian cells

Publications (1)

Publication Number Publication Date
BRPI0417801A true BRPI0417801A (pt) 2007-04-10

Family

ID=35782203

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0417801-7A BRPI0417801A (pt) 2003-12-18 2004-12-16 incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas

Country Status (10)

Country Link
US (4) US7709604B2 (pt)
EP (1) EP1725251A4 (pt)
JP (1) JP4752002B2 (pt)
CN (1) CN1897969B (pt)
AU (2) AU2004321117B2 (pt)
BR (1) BRPI0417801A (pt)
CA (1) CA2549830A1 (pt)
IL (1) IL176010A (pt)
MX (1) MXPA06006868A (pt)
WO (1) WO2006001832A2 (pt)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2128246T3 (da) * 2001-04-19 2014-05-12 Univ California Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.
US20050123970A1 (en) * 2001-04-25 2005-06-09 Can Ozbal High throughput autosampler
US8414774B2 (en) * 2001-04-25 2013-04-09 Agilent Technologies, Inc. Systems and methods for high-throughput screening of fluidic samples
ATE445709T1 (de) * 2002-10-16 2009-10-15 Scripps Research Inst Glycoproteinsynthese
KR101171397B1 (ko) 2003-04-17 2012-08-07 더 스크립스 리서치 인스티튜트 진핵 유전자 코드의 확장
US7993872B2 (en) 2003-06-18 2011-08-09 The Scripps Research Institute Unnatural reactive amino acid genetic code additions
WO2005019415A2 (en) * 2003-07-07 2005-03-03 The Scripps Research Institute Compositions of orthogonal lysyl-trna and aminoacyl-trna synthetase pairs and uses thereof
EP1774018A2 (en) * 2004-05-25 2007-04-18 The Scripps Research Institute Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination
US20060110784A1 (en) * 2004-09-22 2006-05-25 The Scripps Research Institute Site-specific labeling of proteins for NMR studies
CA2583735A1 (en) 2004-10-27 2006-10-19 The Scripps Research Institute Orthogonal translation components for the in vivo incorporation of unnatural amino acids
RU2459866C2 (ru) * 2005-10-12 2012-08-27 Зе Скрипс Ресеч Инститьют Селективная посттрансляционная модификация экспонируемых фагами полипептидов
EP2339014B1 (en) 2005-11-16 2015-05-27 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
CN101400796B (zh) * 2006-03-09 2013-03-27 斯克利普斯研究院 在真细菌宿主细胞内表达正交翻译组分的系统
RU2464315C2 (ru) 2006-03-16 2012-10-20 Зе Скрипс Ресеч Инститьют Генетически запрограммированная экспрессия белков, содержащих не встречающуюся в природе аминокислоту фенилселеноцистеин
JP2009538136A (ja) * 2006-05-23 2009-11-05 ザ スクリップス リサーチ インスティテュート 遺伝的にコードされた蛍光クマリンアミノ酸
US8420792B2 (en) * 2006-09-08 2013-04-16 Ambrx, Inc. Suppressor tRNA transcription in vertebrate cells
CN101516901B (zh) * 2006-09-21 2014-01-08 斯克利普斯研究院 选择性硫酸化的蛋白质在真细菌中的遗传编程表达
AU2007333010A1 (en) 2006-10-18 2008-06-19 The Scripps Research Institute Genetic incorporation of unnatural amino acids into proteins in mammalian cells
US8183037B2 (en) * 2007-04-13 2012-05-22 The Salk Institute For Biological Studies Methods of genetically encoding unnatural amino acids in eukaryotic cells using orthogonal tRNA/synthetase pairs
JP2009017840A (ja) * 2007-07-13 2009-01-29 Japan Agengy For Marine-Earth Science & Technology 外来遺伝子を細胞に安定に保持する方法
JP2009017842A (ja) * 2007-07-13 2009-01-29 Japan Agengy For Marine-Earth Science & Technology 生産性改善法
CA2703736A1 (en) * 2007-10-25 2009-04-30 The Scripps Research Institute Genetic incorporation of 3-aminotyrosine into reductases
WO2009059056A2 (en) * 2007-11-02 2009-05-07 The Scripps Research Institute A genetically encoded boronate amino acid
EP2217356B1 (en) * 2007-11-02 2018-10-17 Biocius Life Sciences, Inc. Devices and methods for coupling mass spectrometry devices with chromatography systems
US9249408B2 (en) * 2007-11-02 2016-02-02 The Scripps Research Institute Directed evolution using proteins comprising unnatural amino acids
CN105647824A (zh) * 2007-12-11 2016-06-08 斯克利普斯研究院 甲基营养酵母菌巴斯德毕赤酵母中的体内非天然氨基酸表达
EP2246428A4 (en) * 2008-02-07 2011-04-13 Univ Tokyo MODIFIED TRNA WITH NON-NATURAL NUCLEOTIDE AND USE THEREOF
MX2010008633A (es) * 2008-02-08 2010-09-30 Scripps Research Inst Ruptura de tolerancia inmunologica con un aminoacido no natural geneticamente codificado.
US20110076718A1 (en) * 2008-02-27 2011-03-31 The Scripps Research Institute In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
EP2370473B1 (en) 2008-12-10 2016-05-11 The Scripps Research Institute Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
US20090197339A1 (en) * 2008-12-10 2009-08-06 The Scripps Research Institute In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
ES2552773T3 (es) 2009-02-27 2015-12-02 Atyr Pharma, Inc. Motivos estructurales de polipéptidos asociados con la actividad de señalización celular
US20130078660A1 (en) * 2010-03-23 2013-03-28 Salk Institute For Biological Studies Methods and compositions for detecting protein modifications
CN103118692A (zh) 2010-04-26 2013-05-22 Atyr医药公司 与半胱氨酰-tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
JP6294074B2 (ja) 2010-04-27 2018-03-14 エータイアー ファーマ， インコーポレイテッド イソロイシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
US8986681B2 (en) 2010-04-27 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl-tRNA synthetases
US8993723B2 (en) 2010-04-28 2015-03-31 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases
CN103118693B (zh) 2010-04-29 2017-05-03 Atyr 医药公司 与缬氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
US8986680B2 (en) 2010-04-29 2015-03-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases
WO2011150279A2 (en) 2010-05-27 2011-12-01 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases
EP2566496B1 (en) 2010-05-03 2018-02-28 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
AU2011248227B2 (en) 2010-05-03 2016-12-01 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
WO2011139988A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases
US8961961B2 (en) 2010-05-03 2015-02-24 a Tyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases
US9062301B2 (en) 2010-05-04 2015-06-23 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutamyl-prolyl-tRNA synthetases
WO2011140267A2 (en) 2010-05-04 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
CN103200953B (zh) 2010-05-14 2017-02-15 Atyr 医药公司 与苯丙氨酰‑β‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
AU2011256366C1 (en) 2010-05-17 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases
EP2575857B1 (en) 2010-06-01 2018-01-24 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
WO2012021249A2 (en) 2010-07-12 2012-02-16 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
AU2011289831C1 (en) 2010-07-12 2017-06-15 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
US8999321B2 (en) 2010-07-12 2015-04-07 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases
CA2804278C (en) 2010-07-12 2021-07-13 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
WO2012027611A2 (en) 2010-08-25 2012-03-01 Atyr Pharma, Inc. INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
EP2624857B1 (en) 2010-10-06 2017-08-02 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl trna synthetases
WO2013022982A2 (en) 2011-08-09 2013-02-14 Atyr Pharma, Inc. Pegylated tyrosyl-trna synthetase polypeptides
WO2013086216A1 (en) 2011-12-06 2013-06-13 Atyr Pharma, Inc. Improved aspartyl-trna synthetases
US9822353B2 (en) 2011-12-06 2017-11-21 Atyr Pharma, Inc. PEGylated aspartyl-tRNA synthetase polypeptides
CA2858613A1 (en) 2011-12-29 2013-08-08 Atyr Pharma, Inc. Aspartyl-trna synthetase-fc conjugates
US20150148525A1 (en) 2012-05-18 2015-05-28 Medical Research Council Methods of incorporating an amino acid comprising a bcn group into a polypeptide using an orthogonal codon encoding it and an orthorgonal pylrs synthase
MX369671B (es) * 2013-03-13 2019-11-15 Genentech Inc Formulaciones con oxidacion reducida.
US20140314778A1 (en) 2013-03-13 2014-10-23 Genentech, Inc. Formulations with reduced oxidation
CN105378075B (zh) 2013-03-15 2022-04-05 Atyr 医药公司 组氨酰-trna合成酶-fc缀合物
GB2528227A (en) 2014-03-14 2016-01-20 Medical Res Council Cyclopropene amino acids and methods
JP2018509172A (ja) * 2015-03-27 2018-04-05 ザ ユニバーシティ オブ クィーンズランド タンパク質への非天然アミノ酸組込みのためのプラットフォーム
JP2020517638A (ja) 2017-04-20 2020-06-18 エータイアー ファーマ， インコーポレイテッド 肺の炎症を治療するための組成物および方法
CN108530544B (zh) * 2018-03-09 2021-10-22 广东药科大学 一种肝癌细胞靶向抗菌肽嵌合体m27-39-htpp及其应用
CN111747869B (zh) * 2020-06-12 2021-10-22 北京大学深圳研究生院 一种遗传编码的甲醛反应性非天然氨基酸、制备方法及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2128246T3 (da) * 2001-04-19 2014-05-12 Univ California Fremgangsmåder og sammensætninger til fremstilling af ortogonale tRNA-aminoacyl-tRNA-syntetasepar.

Also Published As

Publication number Publication date
US8658395B2 (en) 2014-02-25
CN1897969A (zh) 2007-01-17
US7741071B2 (en) 2010-06-22
IL176010A (en) 2012-03-29
JP2007514447A (ja) 2007-06-07
IL176010A0 (en) 2006-10-05
US20050136513A1 (en) 2005-06-23
JP4752002B2 (ja) 2011-08-17
US20070111193A1 (en) 2007-05-17
EP1725251A4 (en) 2009-07-01
MXPA06006868A (es) 2007-03-21
EP1725251A2 (en) 2006-11-29
AU2010212273A1 (en) 2010-09-02
US7709604B2 (en) 2010-05-04
CA2549830A1 (en) 2006-01-05
AU2004321117A1 (en) 2006-01-05
US20110124080A1 (en) 2011-05-26
WO2006001832A3 (en) 2006-03-30
CN1897969B (zh) 2013-09-18
US8242244B2 (en) 2012-08-14
WO2006001832A2 (en) 2006-01-05
US20120282626A1 (en) 2012-11-08
AU2004321117B2 (en) 2010-09-02
AU2010212273B2 (en) 2012-02-16

Similar Documents

Publication Publication Date Title
BRPI0417801A (pt) incorporação seletiva de 5-hidroxitriptofano em proteìnas de células mamìferas
DK1255826T3 (da) Automatisering af proteindesign for proteinbiblioteker
CY1109267T1 (el) Μεθοδοι για την καλλιεργεια κυκλοϊου
CY1106789T1 (el) Γενικος φορεας για στοχευση μοριων σε κυτταρα που εκφραζουν gb3 υποδοχεα
ATE541934T1 (de) Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
HN1999000075A (es) Agonistas y antagonistas il-2 selectivos
AR057614A1 (es) Composiciones y metodos para producir moleculas de union con antigeno hibridas y usos de las mismas
BRPI0507159A (pt) polipeptìdeos em feixe de quatro hélices humanos modificados e seus usos
DK1533380T3 (da) Rekombinant proteinproduktion i en human celle indeholdende mindst ét E1-protein af adenovirus
HN2002000319A (es) Benzamida, heteroarilamida y amidas inversas
NO20043245L (no) Bindingsproteiner som biosensorer
BRPI0519170A8 (pt) formulações de hormônio de crescimento humano que compreendem um aminoácido não naturalmente codificado
HK1132760A1 (en) Site specific incorporation of non-natural amino acids by vertebrate cells
CY1105772T1 (el) Συνθεσεις και μεθοδοι για βελτιωμενη κυτταρικη καλλιεργεια
DK1578949T3 (da) Stedspecifik optagelse af keto-aminnosyrer hos proteiner
BRPI0507856A (pt) composição farmacêutica, e, processo para preparar o anticorpo abeta
DE602004025943D1 (de) Mikrosomvakzin
EA200701528A1 (ru) Новые нутрицевтические композиции
EA200701293A1 (ru) Терапевтическая композиция фактора роста кератиноцитов
BRPI0514411B8 (pt) formulação, e, método de produzir uma formulação
WO2008030613A3 (en) Hybrid suppressor trna for vertebrate cells
CY1105135T1 (el) Ιξωδοελαστικες οφθαλμικες συνθεσεις οι οποιες πepιλαμβανουν υαλουρονικο οξυ και θειϊκη χονδροϊτινη
BRPI0415277A (pt) célula, vetor, método para produzir proteìna gama-carboxilada, proteìna gama-carboxilada isolada, uso da mesma, método para produzir uma composição farmacêutica, composição farmacêutica, método para produzir fator x de humano gama-carboxilado, uso de fator x isolado, método para produzir protrombina de humano gama-carboxilada, uso de protrombina isolada, e, método para promover coagulação aumentada ou diminuìda em um indivìduo
WO2003052084A3 (fr) Construits cellulaires cultives in vitro, preparation et utilisations
EA200501230A1 (ru) Жидкие составы фактор некроза опухоли - связывающих белков

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]